Ultrasound-guided continuous radiofrequency of the C2 dorsal root ganglion for menstrually related migraine: a comparative clinical study.

Menstrually related migraine (MRM) affects many women and causes significant discomfort. It often comes with symptoms like nausea, anxiety, and depression. Traditional treatments, like the medication zolmitriptan, don’t always help. This study looked at a new treatment method called continuous radiofrequency (CRF) targeting the C2 dorsal root ganglion. Researchers compared CRF with zolmitriptan in 69 women with MRM. Patients were divided into two groups: one received zolmitriptan, while the other underwent CRF. The study measured headache intensity, frequency, and duration, as well as nausea and vomiting. Results showed that CRF may reduce headache intensity and frequency more effectively than zolmitriptan. This suggests that CRF could be a promising alternative for women suffering from MRM. The findings could help improve treatment options for those who have not found relief with traditional medications. Clinical relevance: This research indicates that continuous radiofrequency treatment may offer better relief for women with menstrually related migraines than standard medication options.